Who owns MAPLIGHT THERAPEUTICS INC COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Maplight Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Maplight Therapeutics stock

Who bought or sold MAPLIGHT THERAPEUTICS INC COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
T. Rowe Price Investment Management 2.8M $49M 100% Dec 2025
 View chart
Goldman Sachs Group 1.9M $34M 100% Dec 2025
 View chart
Vanguard Group 870k $15M 100% Dec 2025
 View chart
Geode Capital Management 389k $6.8M 100% Dec 2025
 View chart
State Street Corporation 230k $4.0M 100% Dec 2025
 View chart
Lazard Asset Management 208k $3.6M 100% Dec 2025
 View chart
Freestone Grove Partners 184k $3.2M 100% Dec 2025
 View chart
Bnp Paribas Investment Partners 148k $2.6M 100% Dec 2025
 View chart
Charles Schwab Investment Management 138k $2.4M 100% Dec 2025
 View chart
Marshall Wace 40k $697k 100% Dec 2025
 View chart
TD Asset Management 37k $649k 100% Dec 2025
 View chart
Bank of New York Mellon 36k $630k 100% Dec 2025
 View chart
Barclays 26k $464k 100% Dec 2025
 View chart
Wells Fargo & Company 19k $328k 100% Dec 2025
 View chart
UBS Group 18k $321k 100% Dec 2025
 View chart
Rhumbline Advisers 14k $240k 100% Dec 2025
 View chart
Walleye Trading Advisors 12k $205k 100% Dec 2025
 View chart
New York State Common Retirement Fund 5.3k $93k 100% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 3.5k $61k 100% Dec 2025
 View chart
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 3.0k $53k 100% Dec 2025
 View chart
Legal & General Group 1.6k $29k 100% Dec 2025
 View chart
Sterling Capital Management 519.00 $9.1k 100% Dec 2025
 View chart
Farther Finance Advisors 120.00 $2.1k 100% Dec 2025
 View chart